首页> 美国卫生研究院文献>Advances in Nutrition >Effect of Soy and Soy Isoflavones on Obesity-Related Anthropometric Measures: A Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials
【2h】

Effect of Soy and Soy Isoflavones on Obesity-Related Anthropometric Measures: A Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials

机译:大豆和大豆异黄酮对肥胖相关人体测量指标的影响:随机对照临床试验的系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Soy may be a suitable food for anti-obesity efforts because of its high protein and isoflavone content. We conducted this meta-analysis to evaluate potential effects of soy and soy isoflavones on weight, waist circumference, and fat mass. PubMed, MEDLINE, Scopus, EMBASE, and Cochrane databases were searched. Twenty-four trials with soy and 17 trials with isoflavones passed the eligibility stage. According to the results, soy showed no overall statistically significant effect on weight, waist circumference, or fat mass, but a significant increasing effect on weight was observed in some circumstances: for instance, in obese subjects [mean difference (MD): 0.80 kg; 95% CI: 0.15, 1.45 kg; P = 0.02], with ingestions of ≥40 g soy protein/d (MD: 0.94 kg; 95% CI: 0.11, 1.77 kg; P = 0.03), with short-term applications (1–3 mo) (MD: 0.45 kg; 95% CI: 0.05, 0.86 kg; P = 0.03), and when soy was compared with meat (MD: 0.36 kg; 95% CI: 0.09, 0.64 kg; P = 0.03) and whey protein (MD: 1.53 kg; 95% CI: 0.10, 2.96 kg; P = 0.04). In contrast to the effects of soy on weight, soy significantly decreased waist circumference in older ages (MD: −0.36 cm; 95% CI: −0.71, −0.01 cm; P = 0.04), in women (MD: −0.32 cm; 95% CI: −0.57, −0.08 cm; P = 0.01), and at doses of <40 g soy protein/d (MD: −0.31 cm; 95% CI: −0.57, −0.05 cm; P = 0.02). Isoflavone studies, conducted only in women, showed that isoflavones may reduce body mass index (BMI; in kg/m2) (MD: −0.26; 95% CI: −0.55, 0.04; P = 0.085), especially in dosages <100 mg/d (MD: −0.48; 95% CI: −0.90, −0.06; P = 0.02) and in intervention periods of 2–6 mo (MD: −0.28; 95% CI: −0.56, 0.00; P = 0.053), but no effect was observed in higher doses or longer intervention periods. Also, a trend for reduced BMI after consumption of isoflavones was observed in Caucasians (MD: −0.35; 95% CI: −0.74, 0.04; P = 0.08). Overall, results showed that, although soy is the major source of isoflavones, soy and isoflavones may have different impacts on weight status.
机译:大豆由于蛋白质和异黄酮含量高,可能是抗肥胖症的合适食品。我们进行了这项荟萃分析,以评估大豆和大豆异黄酮对体重,腰围和脂肪量的潜在影响。搜索PubMed,MEDLINE,Scopus,EMBASE和Cochrane数据库。合格的阶段包括大豆的24个试验和异黄酮的17个试验。根据结果​​,大豆对体重,腰围或脂肪量没有显示出总体上统计学上显着的影响,但是在某些情况下对体重的观察到了显着的增加作用:例如,在肥胖的受试者中[平均差异(MD):0.80千克; 95%CI:0.15,1.45千克; P = 0.02],每天摄入≥40 g大豆蛋白(MD:0.94 kg; 95%CI:0.11、1.77 kg; P = 0.03),短期使用(1-3 mo)(MD:0.45)千克; 95%CI:0.05,0.86千克; P = 0.03),并且将大豆与肉(MD:0.36千克; 95%CI:0.09,0.64千克; P = 0.03)和乳清蛋白(MD:1.53千克)进行比较; 95%CI:0.10,2.96kg; P = 0.04)。与大豆对体重的影响相反,大豆在女性中年龄较大(MD:-0.36 cm; 95%CI:-0.71,-0.01 cm; P = 0.04),女性(MD:-0.32 cm; 95%CI:-0.57,-0.08 cm; P = 0.01),剂量<40 g大豆蛋白/ d(MD:-0.31 cm; 95%CI:-0.57,-0.05 cm; P = 0.02)。仅在女性中进行的异黄酮研究表明,异黄酮可能会降低体重指数(BMI;以kg / m 2 为单位)(MD:-0.26; 95%CI:-0.55,0.04; P = 0.085 ),尤其是在剂量<100 mg / d(MD:-0.48; 95%CI:-0.90,-0.06; P = 0.02)和2-6 mo的干预期中(MD:-0.28; 95%CI:- 0.56,0.00; P = 0.053),但在更高剂量或更长干预时间下均未观察到效果。同样,在高加索人中,食用异黄酮后观察到BMI降低的趋势(MD:-0.35; 95%CI:-0.74,0.04; P = 0.08)。总体而言,结果表明,尽管大豆是异黄酮的主要来源,但大豆和异黄酮对体重状况的影响可能不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号